Inflammatory cell recruitment in cardiovascular disease: Murine models and potential clinical applications

Clinical Science

Volumn 118, Issue 11, 2010, Pages 641-655

  McNeill, Eileen ^a   Channon, Keith M ^a   Greaves, David R ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apolipoprotein E (ApoE); Atherosclerosis; Cardiovascular disease; Chemokine; Macrophage; Therapy

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR6; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL MIGRATION; EXPERIMENTAL MODEL; HUMAN; INFLAMMATORY CELL; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE ACTIVATION; MONOCYTE; MONOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; MICE; MONOCYTES; TOLL-LIKE RECEPTORS;

EID: 77954080333     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090488     Document Type: Review

References (100)

1. Napoli, C., Glass, C. K., Witztum, J. L., Deutsch, R., D'Armiento, F. P. and Palinski, W. (1999) Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354, 1234-1241
2. Faggiotto, A., Ross, R. and Harker, L. (1984) Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4, 323-340
3. Croce, K. and Libby, P. (2007) Intertwining of thrombosis and inflammation in atherosclerosis. Curr. Opin. Hematol. 14, 55-61
4. Gerrity, R. G. (1981) The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Path. 103, 181-190
5. Faggiotto, A. and Ross, R. (1984) Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4, 341-356
6. Bai, H., Masuda, J., Sawa, Y., Nakano, S., Shirakura, R., Shimazaki, Y., Ogata, J. and Matsuda, H. (1994) Neointima formation after vascular stent implantation: spatial and chronological distribution of smooth muscle cell proliferation and phenotypic modulation. Arterioscler. Thromb. Vasc. Biol. 14, 1846-1853
7. Paigen, B., Morrow, A., Brandon, C., Mitchell, D. and Holmes, P. (1985) Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65-73 (Pubitemid 15247039)
8. Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E. and Herz, J. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893
9. Pendse, A. A., Arbones-Mainar, J. M., Johnson, L. A., Altenburg, M. K. and Maeda, N. (2009) Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J. Lipid Res. 50, S178-S182
10. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M. and Breslow, J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353
11. Zhang, S. H., Reddick, R. L., Piedrahita, J. A. and Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471
12. Knowles, J.W. and Maeda, N. (2000) Genetic modifiers of atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 20, 2336-2345.
13. Linton, M. F., Atkinson, J. B. and Fazio, S. (1995) Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267, 1034-1037
14. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. and Ross, R. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. Vasc. Biol. 14, 133-140
15. Jackson, C. L. (2007) Defining and defending murine models of plaque rupture. Arterioscler. Thromb. Vasc. Biol. 27, 973-977
16. Hansson, G. K. and Heistad, D. D. (2007) Two views on plaque rupture. Arterioscler. Thromb. Vasc. Biol. 27, 697
17. Schwartz, S. M., Galis, Z. S., Rosenfeld, M. E. and Falk, E. (2007) Plaque rupture in humans and mice. Arterioscler. Thromb. Vasc. Biol. 27, 705-713
18. Johnston, B. and Butcher, E. C. (2002) Chemokines in rapid leukocyte adhesion triggering and migration. Semin. Immunol. 14, 83-92
19. Ley, K., Laudanna, C., Cybulsky, M. I. and Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689
20. Evans, R., Patzak, I., Svensson, L., De Filippo, K., Jones, K., McDowall, A. and Hogg, N. (2009) Integrins in immunity. J. Cell Sci. 122, 215-225
21. Laudanna, C., Kim, J. Y., Constantin, G. and Butcher, E. (2002) Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186, 37-46
22. Vestweber, D. (2007) Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 218, 178-196
23. Iiyama, K., Hajra, L., Iiyama, M., Li, H., DiChiara, M., Medoff, B. D. and Cybulsky, M. I. (1999) Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85, 199-207
24. Nakashima, Y., Raines, E.W., Plump, A. S., Breslow, J. L. and Ross, R. (1998) Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 842-851
25. Carson, K. R., Focosi, D., Major, E. O., Petrini, M., Richey, E. A., West, D. P. and Bennett, C. L. (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 10, 816-824
26. Janeway, Jr, C. A. and Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216
27. Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H. H., Brown, G. D. and Gordon, S. (2005) Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23, 901-944
28. Edfeldt, K., Swedenborg, J., Hansson, G. K. and Yan, Z. Q. (2002) Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158-1161 (Pubitemid 34225814)
29. Xu, X. H., Shah, P. K., Faure, E., Equils, O., Thomas, L., Fishbein, M. C., Luthringer, D., Xu, X. P., Rajavashisth, T. B., Yano, J. et al. (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104, 3103-3108
30. Bjorkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T. and Freeman, M. W. (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10, 416-421
31. Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B. and Arditi, M. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A. 101, 10679-10684
32. Mullick, A. E., Tobias, P. S. and Curtiss, L. K. (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115, 3149-3156
33. Mullick, A. E., Soldau, K., Kiosses, W. B., Bell, III, T. A., Tobias, P. S. and Curtiss, L. K. (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J. Exp. Med. 205, 373-383
34. Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J. and Schwartz, D. A. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185-192
35. Yan, Z. Q. and Hansson, G. K. (2007) Innate immunity, macrophage activation, and atherosclerosis. Immunol. Rev. 219, 187-203
36. Frantz, S., Ertl, G. and Bauersachs, J. (2007) Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 4, 444-454
37. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J. and Power, C. A. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176
38. Power, C. A. (2003) Knock out models to dissect chemokine receptor function in vivo. J. Immunol. Methods 273, 73-82
39. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897.
40. Charo, I. F. and Ransohoff, R. M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621
41. Braunersreuther, V., Zernecke, A., Arnaud, C., Liehn, E. A., Steffens, S., Shagdarsuren, E., Bidzhekov, K., Burger, F., Pelli, G., Luckow, B. et al. (2007) Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27, 373-379
42. Zernecke, A., Liehn, E. A., Gao, J. L., Kuziel, W. A., Murphy, P. M. and Weber, C. (2006) Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107, 4240-4243 (Pubitemid 43801346)
43. Veillard, N. R., Kwak, B., Pelli, G., Mulhaupt, F., James, R. W., Proudfoot, A. E. and Mach, F. (2003) Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res. 94, 253-253
44. Bursill, C. A., Choudhury, R. P., Ali, Z., Greaves, D. R. and Channon, K. M. (2004) Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice. Circulation 110, 2460-2466 (Pubitemid 39407354)
45. Bursill, C. A., McNeill, E., Wang, L., Hibbitt, O. C., Wade-Martins, R., Paterson, D. J., Greaves, D. R. and Channon, K. M. (2009) Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition. Gene Ther. 16, 93-102
46. Ali, Z. A., Bursill, C. A., Hu, Y., Choudhury, R. P., Xu, Q., Greaves, D. R. and Channon, K. M. (2005) Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice. Circulation 112, I235-I241
47. Boisvert, W. A., Santiago, R., Curtiss, L. K. and Terkeltaub, R. A. (1998) A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101, 353-363
48. Huo, Y., Weber, C., Forlow, S. B., Sperandio, M., Thatte, J., Mack, M., Jung, S., Littman, D. R. and Ley, K. (2001) The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108, 1307-1314
49. Boisvert, W. A., Rose, D. M., Johnson, K. A., Fuentes, M. E., Lira, S. A., Curtiss, L. K. and Terkeltaub, R. A. (2006) Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am. J. Pathol. 168, 1385-1395
50. Liehn, E. A., Schober, A. and Weber, C. (2004) Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24, 1891-1896
51. Devalaraja, R. M., Nanney, L. B., Du, J., Qian, Q., Yu, Y., Devalaraja, M. N. and Richmond, A. (2000) Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 115, 234-244
52. Del Rio, L., Bennouna, S., Salinas, J. and Denkers, E. Y. (2001) CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J. Immunol. 167, 6503-6509
53. Shimaoka, T., Kume, N., Minami, M., Hayashida, K., Kataoka, H., Kita, T. and Yonehara, S. (2000) Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 275, 40663-40666
54. Wuttge, D. M., Zhou, X., Sheikine, Y., Wagsater, D., Stemme, V., Hedin, U., Stemme, S., Hansson, G. K. and Sirsjo, A. (2004) CXCL16/SR-PSOX is an interferon-γ-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 24, 750-755
55. Galkina, E., Harry, B. L., Ludwig, A., Liehn, E. A., Sanders, J. M., Bruce, A., Weber, C. and Ley, K. (2007) CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-γ production, and macrophage accumulation in the aortic wall. Circulation 116, 1801-1811
56. Aslanian, A. M. and Charo, I. F. (2006) Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114, 583-590
57. Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K. and Silverstein, R. L. (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105, 1049-1056
58. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T. et al. (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-296
59. Bazan, J. F., Bacon, K. B., Hardiman, G.,Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A. and Schall, T. J. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644
60. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J. and Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530
61. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111, 333-340.
62. Teupser, D., Pavlides, S., Tan, M., Gutierrez-Ramos, J. C., Kolbeck, R. and Breslow, J. L. (2004) Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc. Natl. Acad. Sci. U.S.A. 101, 17795-17800
63. Koenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A. et al. (2009) Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15, 97-103
64. Weber, C. and Koenen, R. R. (2006) Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol. 27, 268-273
65. Lessner, S. M., Prado, H. L., Waller, E. K. and Galis, Z. S. (2002) Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am. J. Pathol. 160, 2145-2155
66. Kircher, M. F., Grimm, J., Swirski, F. K., Libby, P., Gerszten, R. E., Allport, J. R. and Weissleder, R. (2008) Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117, 388-395
67. Swirski, F. K., Pittet, M. J., Kircher, M. F., Aikawa, E., Jaffer, F. A., Libby, P. and Weissleder, R. (2006) Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. U.S.A. 103, 10340-10345
68. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G. and Geissmann, F. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670 (Pubitemid 47229966)
69. Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J. L., Kohler, R. H., Chudnovskiy, A.,Waterman, P. et al. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616
70. Auffray, C., Sieweke, M. H. and Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692
71. Geissmann, F., Jung, S. and Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (Pubitemid 36859902)
72. Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R. and Pittet, M. J. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195-205
73. Tsou, C. L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M. and Charo, I. F. (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909
74. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N. et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194
75. lo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649-1657
76. hi monocyte recruitment to sites of atherosclerosis in mice. Circulation 117, 3227-3237
77. + monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119, 2708-2717
78. Williams, K. J., Feig, J. E. and Fisher, E. A. (2008) Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat. Clin. Pract. Cardiovasc. Med. 5, 91-102
79. Reis, E. D., Li, J., Fayad, Z. A., Rong, J. X., Hansoty, D., Aguinaldo, J. G., Fallon, J. T. and Fisher, E. A. (2001) Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J. Vasc. Surg. 34, 541-547
80. Trogan, E., Fayad, Z. A., Itskovich, V. V., Aguinaldo, J. G., Mani, V., Fallon, J. T., Chereshnev, I. and Fisher, E. A. (2004) Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 24, 1714-1719
81. Llodra, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A. and Randolph, G. J. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U.S.A. 101, 11779-11784
82. Trogan, E., Feig, J. E., Dogan, S., Rothblat, G. H., Angeli, V., Tacke, F., Randolph, G. J. and Fisher, E. A. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 103, 3781-3786
83. Lieu, H. D.,Withycombe, S. K., Walker, Q., Rong, J. X., Walzem, R. L., Wong, J. S., Hamilton, R. L., Fisher, E. A. and Young, S. G. (2003) Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107, 1315-1321 (Pubitemid 36314417)
84. Raffai, R. L. and Weisgraber, K. H. (2002) Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J. Biol. Chem. 277, 11064-11068
85. Raffai, R. L., Loeb, S. M. and Weisgraber, K. H. (2005) Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 25, 436-441
86. Ehlers, S. (2005) Why does tumor necrosis factor targeted therapy reactivate tuberculosis? J. Rheumatol. Suppl. 74, 35-39
87. Mackay, C. R. (2008) Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat. Immunol. 9, 988-998
88. Gautier, E. L., Jakubzick, C. and Randolph, G. J. (2009) Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1412-1418
89. Sata, M., Maejima, Y., Adachi, F., Fukino, K., Saiura, A., Sugiura, S., Aoyagi, T., Imai, Y., Kurihara, H., Kimura, K. et al. (2000) A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J. Mol. Cell. Cardiol. 32, 2097-2104
90. Lindner, V., Fingerle, J. and Reidy, M. A. (1993) Mouse model of arterial injury. Circ. Res. 73, 792-796
91. Kumar, A. and Lindner, V. (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17, 2238-2244
92. Eschert, H., Sindermann, J. R., Scheld, H. H., Breithardt, G. and Weissen-Plenz, G. (2009) Vascular remodeling in ApoE-deficient mice: diet dependent modulation after carotid ligation. Atherosclerosis 204, 96-104
93. Nam, D., Ni, C. W., Rezvan, A., Suo, J., Budzyn, K., Llanos, A., Harrison, D., Giddens, D. and Jo, H. (2009) Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 297, H1535-H1543
94. Cheng, C., Tempel, D., van Haperen, R., van der Baan, A., Grosveld, F., Daemen, M. J., Krams, R. and de Crom, R. (2006) Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 113, 2744-2753 (Pubitemid 43947992)
95. Moroi, M., Zhang, L., Yasuda, T., Virmani, R., Gold, H. K., Fishman, M. C. and Huang, P. L. (1998) Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest. 101, 1225-1232
96. Lardenoye, J. H., Delsing, D. J., de Vries, M. R., Deckers, M. M., Princen, H. M., Havekes, L. M., van Hinsbergh, V. W., van Bockel, J. H. and Quax, P. H. (2000) Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. Circ. Res. 87, 248-253
97. Ali, Z. A., Alp, N. J., Lupton, H., Arnold, N., Greaves, D. R., Hu, Y., Gunn, J. and Channon, K. M. (2007) Increased in-stent stenosis in ApoE-knockout mice: a novel mouse model of angioplasty and stenting. Arterioscler. Thromb. Vasc. Biol. 27, 833-840
98. Baker, A. B., Groothuis, A., Jonas, M., Ettenson, D. S., Shazly, T., Zcharia, E., Vlodavsky, I., Seifert, P. and Edelman, E. R. (2009) Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice. Circ. Res. 104, 380-387
99. Dietrich, H., Hu, Y., Zou, Y., Huemer, U., Metzler, B., Li, C., Mayr, M. and Xu, Q. (2000) Rapid development of vein graft atheroma in ApoE-deficient mice. Am. J. Path. 157, 659-669
100. Zou, Y., Dietrich, H., Hu, Y., Metzler, B.,Wick, G. and Xu, Q. (1998) Mouse model of venous bypass graft atherosclerosis. Am. J. Path. 153, 1301-1310